Thursday, February 07, 2008 12:09:19 PM
Tuesday February 5, 8:00 am ET
Participation Includes Corporate Presentation and Antibiotic Panel; Corporate Presentation to be Webcast Live
CAMBRIDGE, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Targanta Therapeutics Corporation (Nasdaq: TARG - News) today announced its participation in the Biotechnology Industry Organization's CEO & Investor Conference, taking place from February 11th through February 13th at the Waldorf~Astoria Hotel in New York City.
http://biz.yahoo.com/prnews/080205/nytu029.html?.v=101
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM